OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Nuclear Medicine is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Effect of COVID-19 Lockdown on Oncologic Patients Undergoing Treatment at a Tertiary-Care Hospital in India	178
Prostate-Specific Membrane Antigen Expression on PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer: A Retrospective Observational Study	161
Practicing Medicine in Wartime Ukraine	148
Noninvasive Assessment of Acute Graft-Versus-Host Disease of the Gastrointestinal Tract After Allogeneic Hemopoietic Stem Cell Transplantation Using¹⁸F-FDG PET	129
Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls	113
Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor PET in a Human-Sized Swine Model	100
Validation of¹⁸F-rhPSMA-7 and¹⁸F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer	97
Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET	93
Distinction of Lymphoma from Sarcoidosis on¹⁸F-FDG PET/CT: Evaluation of Radiomics-Feature–Guided Machine Learning Versus Human Reader Performance	88
Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma	85
Dynamic Tumor-Specific MHC-II Immuno-PET Predicts Checkpoint Inhibitor Immunotherapy Efficacy in Melanoma	84
Image-Guided High-Intensity Focused Ultrasound, A Novel Application for Interventional Nuclear Medicine?	83
Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [¹⁸F]PSMA-1007 PET/CT	80
Albumin-Binding and Conventional PSMA Ligands in Combination with¹⁶¹Tb: Biodistribution, Dosimetry, and Preclinical Therapy	78
Imaging Neuroinflammation in Neurodegenerative Disorders	75
Challenges and Promise for Nuclear Medicine in Africa	74
Stacking Ensemble Learning–Based [¹⁸F]FDG PET Radiomics for Outcome Prediction in Diffuse Large B-Cell Lymphoma	74
Letter to the Editor: “¹⁸F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study” [J Nucl Med 2022; 63:147–157]	74
Perspectives on Theranostics and Nuclear Medicine	73
Myocardial External Efficiency in Asymptomatic Severe Primary Mitral Regurgitation Using¹¹C-Acetate PET	71
PET-Based Staging Is Cost-Effective in Early-Stage Follicular Lymphoma	65
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma	61
¹¹C-PiB and¹²⁴I-Antibody PET Provide Differing Estimates of Brain Amyloid-β After Therapeutic Intervention	56
A Model System to Explore the Detection Limits of Antibody-Based Immuno-SPECT Imaging of Exclusively Intranuclear Epitopes	53
Deep Learning–Enabled Quantification of^99mTc-Pyrophosphate SPECT/CT for Cardiac Amyloidosis	52

Explainable Deep Learning Improves Physician Interpretation of Myocardial Perfusion Imaging	52
Advancing Clinical Trial Innovation in Pancreatic Cancer	51
Reply: What Does an Imaging “Selection” Claim Actually Mean?	51
A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study	50
Longitudinal Tau PET Using¹⁸F-Flortaucipir: The Effect of Relative Cerebral Blood Flow on Quantitative and Semiquantitative Parameters	50
Adding Nontumor Radiomic Features to the Prognostic Model Is Bothersome but Useful	49
Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of^99mTc and¹⁸⁸Re Theranostic Agents for Prostate Cancer	48
Cyclooxygenases as Potential PET Imaging Biomarkers to Explore Neuroinflammation in Dementia	47
¹⁷⁷Lu-PSMA (R)Evolution in Cancer Care: Is It Really Happening?	47
⁶⁸Ga-PSMA PET/CT–Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines	47
Diagnostic Accuracy of MR Spectroscopic Imaging and¹⁸F-FET PET for Identifying Glioma: A Biopsy-Controlled Hybrid PET/MRI Study	47
Advancing Nuclear Medicine in Australia over 3 Decades	46
A Life in Nuclear Medicine in Israel	46
Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Directed Radioligand Therapy	45
Biokinetics and Dosimetry of [¹⁷⁷Lu]Lu-Pentixather	45
Automated Motion Correction for Myocardial Blood Flow Measurements and Diagnostic Performance of⁸²Rb PET Myocardial Perfusion Imaging	44
A Life Study in Academic Leadership	44
Hemodynamic Insights into Combined Fractional Flow Reserve and Instantaneous Wave-Free Ratio Assessment Through Quantitative [¹⁵O]H₂O PET Myocardial Perfusion Imaging	43
Determining Hemodynamically Significant Coronary Artery Disease: Patient-Specific Cutoffs in Quantitative Myocardial Blood Flow Using [¹⁵O]H₂O PET Imaging	43
Update on the Evaluation of Thyroid Nodules	43
A Phase II, Open-Label Study to Assess Safety and Management Change Using ⁶⁸Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Tre	43